A detailed history of Portolan Capital Management, LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 663,602 shares of HCAT stock, worth $4.88 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
663,602
Holding current value
$4.88 Million
% of portfolio
0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.48 - $8.83 $3.64 Million - $5.86 Million
663,602 New
663,602 $5.4 Million
Q3 2022

Nov 14, 2022

SELL
$9.3 - $18.27 $2.36 Million - $4.63 Million
-253,625 Reduced 45.52%
303,602 $2.95 Million
Q2 2022

Aug 15, 2022

BUY
$11.79 - $27.63 $3.3 Million - $7.73 Million
279,820 Added 100.87%
557,227 $8.07 Million
Q1 2022

May 16, 2022

BUY
$20.67 - $40.33 $5.73 Million - $11.2 Million
277,407 New
277,407 $7.25 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $403M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.